EML5
Echinoderm microtubule-associated protein-like 5
Also known as: EMAL5_HUMAN, EMAP-2, FAP16, HuEMAP-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q05BV3
- Gene
- EML5
- Ensembl
- ENSG00000165521
- Chromosome
- 14
- Canonical length
- 1969 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable microtubule binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1969 residues, UniProt reviewed canonical sequence.
>Q05BV3|EML5
1 MAARSAPSCH LRLEWVYGYR GHQCRNNLYY TAAKEIVYFV AGVGVVYSPR EHRQKFYRGH
61 SDDIISLALH PERVLVATGQ VGKEPYICIW DSYTVQTISV LKDVHTHGIA CLAFDLDGQR
121 LVSVGLDSKN AVCVWDWKRG KMLSMAPGHT DRIFDISWDL YQPNKLVSCG VKHIKFWSLC
181 GNALTPKRGV FGKTGDLQTI LCLACARDEL TYSGALNGDI YVWKGINLIR TIQGAHAAGI
241 FSMNACEEGF ATGGRDGCIR LWDLTFKPIT VIDLRETDQG YKGLSVRSVC WRGDHILVGT
301 QDSEIFEIVV QERNKPFLIM QGHCEGELWA LAVHPTKPLA VTGSDDRSVR IWSLVDHALI
361 ARCNMEEPIR CAAVNADGIH LALGMKDGSF TVLRVRDMTE VVHIKDRKEA IHELKYSPDG
421 TYLAVGCNDS SVDIYGVAQR YKKVGECLGS LSFITHLDWS SDSRYLQTND GNGKRLFYRM
481 PGGKEVTSTE EIKGVHWASW TCVSGLEVNG IWPKYSDIND INSVDGNYIG QVLVTADDYG
541 IIKLFRYPCL RKGAKFRKYI GHSAHVTNVR WSHDYQWVIS IGGADHSVFQ WKFIPERKLK
601 DAVHIAPQES LADSHSDESD SDLSDVPELD SEIEQETQLT YRRQVYKEDL PQLKEQCKEK
661 QKSATSKRRE RAPGNSIRLH FVHGYRGYDC RSNLFYTQIG EIVYHVAAVG VIYNRQQNTQ
721 RFYLGHDDDI LCLTIHPLKD YVATGQVGRD PSIHIWDTET IKPLSILKGH HQYGVSAVDF
781 SADGKRLASV GIDDSHTVVL WDWKKGEKLS IARGSKDKIF VVKMNPYVPD KLITAGIKHM
841 KFWRKAGGGL IGRKGYIGTL GKNDTMMCAV YGWTEEMAFS GTSTGDVCIW RDIFLVKTVK
901 AHDGPVFSMH ALEKGFVTGG KDGIVALWDD SFERCLKTYA IKRAALAPGS KGLLLEDNPS
961 IRAISLGHGH ILVGTKNGEI LEVDKSGPIT LLVQGHMEGE VWGLATHPYL PICATVSDDK
1021 TLRIWDLSPS HCMLAVRKLK KGGRCCCFSP DGKALAVGLN DGSFLMANAD TLEDLVSFHH
1081 RKDMISDIRF SPGSGKYLAV ASHDSFIDIY NVMSSKRVGI CKGATSYITH IDWDIRGKLL
1141 QVNTGAKEQL FFEAPRGKKQ TIPSVEVEKI AWASWTSVLG LCCEGIWPVI GEVTDVTASC
1201 LTSDKMVLAT GDDLGFVKLF RYPTKGKFGK FKRYVAHSTH VTNVRWTYDD SMLVTLGGTD
1261 MSLMVWTNEM EGYREKRPCD SEESDIDSEE DGGYDSDVTR ENEISYTIRA LSTNIRPMLG
1321 IKPHLQQKEP SIDERPPVSR APPQPEKLQT NNVGKKKRPI EDLVLELIFG YRGRDCRNNV
1381 HYLNDGDDII YHTASVGILH NVATGSQSFY QEHNDDILCL TVNQHPKFIN IVATGQVGDS
1441 ADMSATAPSI HIWDAMNKQT LSILRCYHSK GVCSVSFSAT GKLLLSVGLD PEHTITIWRW
1501 QEGAKIASRA GHNQRIFVAE FRPDSDTQFV SVGVKHVKFW TLAGRALLSK KGLLSTLEDA
1561 RMQTMLAIAF GANNLTFTGT ISGDVCVWKD HILCRIVARA HNGPVFAMYT TLRDGLIVTG
1621 GKERPSKEGG AVKLWDQELR RCRAFRLETG QATDCVRSVC RGKGKILVGT RNAEIIEVGE
1681 KNAACNILVN GHVDGPIWGL ATHPSRDFFL SAAEDGTVRL WDIADKKMLN KVNLGHAART
1741 VCYSPEGDMV AIGMKNGEFI ILLVSSLKIW GKKRDRRCAI HDIRFSPDSR YLAVGSSENS
1801 VDFYDLTLGP TLNRISYCKD IPSFVIQMDF SADSSYLQVS SGCYKRHVYE VPSGKHLMDH
1861 AAIDRITWAT WTSILGDEVL GIWSRHAEKA DVNCACVSHS GISLVTGDDF GMVKLFDFPC
1921 PEKFAKHKRF LGHSPHVTNI RFTSGDRHVV SAGGDDCSLF VWKCVHTPHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EML5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- ovary: 10 nTPM
- retina: 8.4 nTPM
- prostate: 4 nTPM
- adrenal gland: 3.5 nTPM
- cerebellum: 2.6 nTPM
- parathyroid gland: 2.2 nTPM
Single-cell type
- adrenal medulla cells: 872 nCPM
- retinal ganglion cells: 576 nCPM
- granulosa cells: 541 nCPM
- prostatic glandular cells: 383 nCPM
- thyrotrophs: 368 nCPM
- cone photoreceptor cells: 335 nCPM
Immune cell
- MAIT T-cell: 0.2 nTPM
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 44 nTPM
- midbrain: 18 nTPM
- hippocampal formation: 14 nTPM
- amygdala: 13 nTPM
- basal ganglia: 13 nTPM
- thalamus: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.9
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WD40 repeat
- HELP motif
- Soluble quinoprotein glucose/sorbosone dehydrogenase, beta-propeller domain superfamily
- Quinoprotein alcohol dehydrogenase-like superfamily
- WD40/YVTN repeat-like-containing domain superfamily
- WD40 repeat, conserved site
- WD40-repeat-containing domain superfamily
- WD repeat Echinoderm Microtubule-associated Protein-like
- EML-like, first beta-propeller domain
- EML-like, second beta-propeller domain
- HELP motif
- Echinoderm microtubule-associated protein first beta-propeller
- Echinoderm microtubule-associated protein second beta-propeller
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EML5 as an antibody target. Whether an autoantibody or antibody against EML5 could matter depends on whether native EML5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EML5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EML5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...